This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Robinson-Smith, T. M. Articles by Drew, A. F. Search for Related Content PubMed PubMed Citation Articles by Robinson-Smith, T. M. Articles by Drew, A. F.

Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice

¹ Department of Pathology and Laboratory Medicine and ² Division of Gynecologic Oncology; ³ Department of Genome Science, Genome Research Institute, University of Cincinnati, Cincinnati, Ohio; ⁴ Department of Biochemistry and Molecular Biology, Wright State University, Dayton, Ohio; and ⁵ Department of Cell Biology and Immunology, Free University, Amsterdam, the Netherlands

Requests for reprints: Angela F. Drew, Genome Research Institute, University of Cincinnati, 2180 East Galbraith Road, Cincinnati, OH 45237. Phone: 513-558-8691; E-mail: angela.drew{at}uc.edu.

The tumor microenvironment is known to have a profound effect on tumor progression in a highly context-specific manner. We have investigated whether peritoneal inflammation plays a causative role in ovarian tumor metastasis, a poorly understood process. Implantation of human ovarian tumor cells into the ovaries of severe combined immunodeficient mice resulted in peritoneal inflammation that corresponds temporally with tumor cell dissemination from the ovaries. Enhancement of the inflammatory response with thioglycolate accelerated the development of ascites and metastases. Suppression of inflammation with acetyl salicylic acid delayed ascites development and reduced tumor implant formation. A similar prometastatic effect for inflammation was observed when tumor cells were injected directly into the peritoneum of severe combined immunodeficient mice, and in a syngeneic immunocompetent mouse model. Inflammation-modulating treatments did not affect primary tumor development or in vitro tumor cell growth. Depletion of peritoneal macrophages, but not neutrophils or natural killer cells, reduced tumor progression, as assessed by ascites formation and peritoneal metastasis. We conclude that inflammation facilitates ovarian tumor metastasis by a mechanism largely mediated by macrophages, and which may involve stromal vascular endothelial growth factor production. The confirmation of these findings in immunocompetent mice suggests relevance to human disease. Identifying the mechanisms by which macrophages contribute to tumor metastasis may facilitate the development of new therapies specifically targeting immune cell products in the tumor microenvironment. [Cancer Res 2007;67(12):5708–16]

This article has been cited by other articles:

				N. R. Miselis, Z. J. Wu, N. Van Rooijen, and A. B. Kane Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma Mol. Cancer Ther., April 1, 2008; 7(4): 788 - 799. [Abstract] [Full Text] [PDF]